Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

ClinicalTrials.gov ID: NCT00986154

Public ClinicalTrials.gov record NCT00986154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluation of heparin/edoxaban tosylate (DU176b) versus heparin/warfarin in preventing recurrence of blood clots in patients with acute symptomatic deep-vein blood clots in the legs and/or blood clots in the lungs.

Study identification

NCT ID
NCT00986154
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
8,292 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2009 (Type not available)
Primary completion
Apr 2013 (Actual)
Completion
Apr 2013 (Actual)
Last update posted
Mar 5, 2019

2009 – 2013

United States locations

U.S. sites
82
U.S. states
25
U.S. cities
74
Facility City State ZIP Site status
Investigational Site 7103 Mobile Alabama 36608 —
Investigational Site 7132 Montgomery Alabama 36116 —
Investigational Site 7126 Phoenix Arizona 85006 —
Investigational Site 7139 Little Rock Arkansas 72205 —
Investigational Site 1070 Anaheim California 92801 —
Investigational Site 7125 Los Alamitos California 90720 —
Investigational Site 1093 Monterey California 93940 —
Investigational Site 1069 Palm Springs California 92262 —
Investigational Site 7150 San Diego California 92123 —
Investigational Site 1089 Vista California 92083 —
Investigational Site 1012 Aurora Colorado 80012 —
Investigational Site 1013 Boulder Colorado 80303 —
Investigational Site 1017 Denver Colorado 80218 —
Investigational Site 1018 Lakewood Colorado 80228 —
Investigational Site 1019 Littleton Colorado 80120-4413 —
Investigational Site 1022 Thornton Colorado 80260 —
Investigational Site 1023 Thornton Colorado 80260 —
Not listed Brandon Florida — —
Investigational Site 1071 Clearwater Florida 33756 —
Investigational Site 7117 Fort Myers Florida 33907 —
Investigational Site 7106 Gainesville Florida 32605 —
Investigational Site 1005 Ocoee Florida 34761 —
Investigational Site 1006 Orlando Florida 32806 —
Investigational Site 7144 Sarasota Florida 34232 —
Investigational Site 7127 St. Petersburg Florida 33707 —
Investigational Site 1007 Winter Park Florida 32789 —
Investigational Site 7104 Albany Georgia 31701 —
Investigational Site 1095 Columbus Georgia 31904 —
Investigational Site 1080 Jonesboro Georgia 30236 —
Investigational Site 7146 Savannah Georgia 31419 —
Investigational Site 1098 Park Ridge Illinois 60068 —
Not listed Carmel Indiana — —
Investigational Site 7115 Paducah Kentucky 42003 —
Investigational Site 1065 Covington Louisiana 70433 —
Investigational Site 1068 Baltimore Maryland 21215 —
Investigational Site 1037 Westminster Maryland 21157 —
Investigational Site 1038 Westminster Maryland 21157 —
Investigational Site 7133 Kansas City Missouri 64128 —
Investigational Site 7147 Butte Montana 59701 —
Investigational Site 1039 Las Vegas Nevada 89169 —
Investigational Site 7143 Rochester New York 14642 —
Investigational Site 7135 Durham North Carolina 27710 —
Investigational Site 7145 Statesville North Carolina 28625 —
Investigational Site 7138 Maumee Ohio 43537 —
Investigational Site 7122 Toledo Ohio 43606 —
Investigational Site 7152 Bend Oregon 97701 —
Not listed Portland Oregon — —
Investigational Site 1004 Camp Hill Pennsylvania 17011 —
Investigational Site 7109 Ephrata Pennsylvania 17522 —
Investigational Site 1049 Kingston Pennsylvania 18704 —
Investigational Site 7109 Lancaster Pennsylvania 17602 —
Investigational Site 7154 Sellersville Pennsylvania — —
Investigational Site 7128 Uniontown Pennsylvania — —
Investigational Site 1031 Easley South Carolina 29640 —
Investigational Site 1032 Greenville South Carolina 29605 —
Investigational Site 1034 Greenville South Carolina 29605 —
Investigational Site 1033 Greenville South Carolina 29615 —
Investigational Site 1035 Seneca South Carolina 29672 —
Investigational Site 1036 Spartanburg South Carolina 29307 —
Investigational Site 1009 Arlington Texas 76014-2084 —
Investigational Site 1050 Dallas Texas — —
Investigational Site 1047 Fort Worth Texas 76104 —
Investigational Site 7105 Fort Worth Texas 76109 —
Investigational Site 1048 Fort Worth Texas 76132 —
Investigational Site 1059 Midland Texas — —
Investigational Site 1040 New Braunfels Texas 78130 —
Investigational Site 1041 Odessa Texas — —
Investigational Site 1002 San Antonio Texas 78229 —
Investigational Site 1058 Sugar Land Texas — —
Investigational Site 1042 Tyler Texas — —
Investigational Site 1008 Waco Texas — —
Investigational Site 7123 Salt Lake City Utah — —
Investigational Site 1003 Fredericksburg Virginia — —
Investigational Site 1025 Newport News Virginia — —
Investigational Site 1024 Norfolk Virginia — —
Investigational Site 1066 Randallstown Virginia — —
Investigational Site 1030 Virginia Beach Virginia — —
Investigational Site 7120 Seattle Washington — —
Investigational Site 1076 Tacoma Washington — —
Investigational Site 1053 Vancouver Washington — —
Investigational Site 1056 Vancouver Washington — —
Investigational Site 1057 Vancouver Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 372 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00986154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2019 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00986154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →